Global Myopia And Presbyopia Treatment Market To 2028 – – Tips & Results

DUBLIN, April 21, 2022 (GLOBE NEWSWIRE) — The ‘Global Myopia and Presbyopia Treatments Market Size, Share and Trends Analysis Report by Myopia Treatment Type (Corrective, Surgical), Presbyopia Treatment Type (Prescription, Contact Lenses), Region and Segment Forecasts, 2021-2028” was added to the report ResearchAndMarkets.com Offer.

According to the report, the global myopia and presbyopia treatment market is expected to reach US$28.0 billion by 2028. The market is expected to grow at a CAGR of 7.9% from 2021 to 2028.

The increasing research and development in the target diseases is expected to significantly propel the market during the forecast period. Furthermore, the increasing prevalence of myopia and severe myopia is expected to drive the market over the forecast period. Myopia incidences in Asia-Pacific developing countries such as Japan, China, Singapore and the Republic of Korea have increased significantly in recent years. According to Statista, cases of myopia are expected to increase by 28% worldwide over the next ten years, and by 30% for high myopia.

The increasing prevalence of myopia and presbyopia is an opportunity for industry players to introduce efficient treatment solutions. Among developed nations, the US is witnessing a significant increase in the incidence of myopia and presbyopia, particularly among those over 42 years of age. The introduction of technologically advanced surgical options and high adoption rates in developed countries are expected to fuel the market growth in the coming years.

Advanced diagnostic and surgical treatment solutions include LASIK, LASEK and PRK. The integration of these techniques with artificial intelligence and robotic surgical instruments is expected to increase the number of surgical procedures. The introduction of multifocal intraocular lenses and implantable contact lenses should have a positive impact on the market growth.

Highlights of the Myopia and Presbyopia Treatment market report

  • By type of myopia treatment, the single-prescription corrective lens segment is expected to hold a significant revenue share of the market due to the progression of myopia with age, which requires frequent changing of corrective lenses
  • The progressive multifocal lens segment is also likely to grow significantly over the forecast period due to wide acceptance due to aesthetic benefits
  • Multifocal contact lenses for the correction of presbyopia accounted for the largest share of sales in 2020, mainly due to easy availability and effective results

Main topics covered:

Chapter 1. Methodology and scope

Chapter 2. Summary

Chapter 3. Market Variables, Trends and Scope of Myopia and Presbyopia Treatment
3.1. Outlook on the market lineage
3.1.1. Prospects for the parent market
3.1.2. Related/additional market prospects
3.2. Mapping penetration and growth prospects
3.3. Industry value chain analysis
3.3.1. compensation framework
3.4. market dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Constraint Analysis
3.4.3. Industry Challenges
3.5. Market analysis tools for the treatment of myopia and presbyopia
3.5.1. Industry Analysis – Porter’s
3.5.1.1. supplier performance
3.5.1.2. buyer power
3.5.1.3. threat of substitution
3.5.1.4. Threat of newcomers
3.5.1.5. competition
3.5.2. PESTEL analysis
3.5.2.1. political landscape
3.5.2.2. technological landscape
3.5.2.3. economic landscape
3.5.3. Analysis of major deals and strategic alliances
3.5.4. Market Entry Strategies

Chapter 4. Myopia Treatment Type Estimates and Trend Analysis
4.1. Definitions and Scope
4.1.1. Corrective
4.1.1.1. Prescription lenses
4.1.1.1.1. single
4.1.1.1.2. Bifocal
4.1.1.1.3. trifocal
4.1.1.1.4. Other
4.1.1.2. contact lenses
4.1.2. surgical
4.1.3. drugs
4.2. Market share by type of myopia treatment, 2020 and 2028
4.3. Segment Dashboard
4.4. Global Myopia and Presbyopia Treatment Market by Myopia Treatment Type Outlook
4.5. Market Size & Forecasts and Trend Analysis, 2018 to 2028 for the following
4.5.1. Corrective
4.5.1.1. Prescription lenses
4.5.1.1.1. single
4.5.1.1.2. Bifocal
4.5.1.1.3. trifocal
4.5.1.1.4. Other
4.5.1.2. contact lenses
4.5.2. surgical
4.5.3. drugs

Chapter 5. Presbyopia Treatment Type Estimates and Trend Analysis
5.1. Definitions and Scope
5.1.1. Prescription lenses
5.1.1.1. reading glasses
5.1.1.2. bifocals
5.1.1.3. trifocal
5.1.1.4. Progressive multifocal glasses
5.1.1.5. Office progressive
5.1.2. contact lenses
5.1.2.1. Bifocal
5.1.2.2. multifocal
5.1.2.3. monovision
5.1.2.4. Modified mono vision
5.1.3. intraocular lenses
5.1.4. refractive surgery
5.2. Presbyopia Treatment Type Market Share, 2020 and 2028
5.3. Segment Dashboard
5.4. Global Myopia and Presbyopia Treatment Market by Presbyopia Treatment Type Outlook
5.5. Market Size & Forecasts and Trend Analysis, 2018 to 2028 for the following
5.5.1. Prescription lenses
5.5.1.1. reading glasses
5.5.1.2. bifocals
5.5.1.3. trifocal
5.5.1.4. Progressive multifocal glasses
5.5.1.5. Office progressive
5.5.2. contact lenses
5.5.2.1. Bifocal
5.5.2.2. multifocal
5.5.2.3. monovision
5.5.2.4. Modified mono vision
5.5.3. intraocular lenses
5.5.4. refractive surgery

Chapter 6. Treatment of Myopia and Presbyopia: Regional Estimates and Trend Analysis

Chapter 7. Competitive landscape
7.1. Recent developments and impact analysis by major market players
7.2. Company/competition categorization
7.2.1. innovators
7.3. provider landscape
7.3.1. List of major distributors and sales partners
7.3.2. key customers
7.3.3. Market share analysis of major companies, 2018
7.3.4. Zeimer Ophthalmic Systems AG
7.3.4.1. company overview
7.3.4.2. financial performance
7.3.4.3. Product Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. NIDEK CO. LTD.
7.3.5.1. company overview
7.3.5.2. financial performance
7.3.5.3. Product Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. Johnson & Johnson Vision
7.3.6.1. company overview
7.3.6.2. financial performance
7.3.6.3. Product Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. ZEISS International
7.3.7.1. company overview
7.3.7.2. financial performance
7.3.7.3. Product Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. ALCON VISION LLC
7.3.8.1. company overview
7.3.8.2. financial performance
7.3.8.3. Product Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. Bausch & Lomb Incorporated
7.3.9.1. company overview
7.3.9.2. financial performance
7.3.9.3. Product Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. Hague-Streit UK
7.3.10.1. company overview
7.3.10.2. financial performance
7.3.10.3. Product Benchmarking
7.3.10.4. Strategic Initiatives
7.3.11. Topcon Corporation
7.3.11.1. company overview
7.3.11.2. financial performance
7.3.11.3. Product Benchmarking
7.3.11.4. Strategic Initiatives
7.3.12. Essilor Ltd.
7.3.12.1. company overview
7.3.12.2. financial performance
7.3.12.3. Product Benchmarking
7.3.12.4. Strategic Initiatives

For more information about this report, visit https://www.researchandmarkets.com/r/717wbb

  • Global Myopia and Presbyopia Treatment Market


        

Leave a Comment